Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherCLINICAL INVESTIGATIONS

Ipsilateral and Contralateral Thalamic Hypometabolism as a Predictor of Outcome After Temporal Lobectomy for Seizures

Andrew B. Newberg, Abass Alavi, Jesse Berlin, P. David Mozley, Michael O'Connor and Michael Sperling
Journal of Nuclear Medicine December 2000, 41 (12) 1964-1968;
Andrew B. Newberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abass Alavi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jesse Berlin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. David Mozley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael O'Connor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Sperling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

FDG PET is often used to help localize the seizure focus before surgery in patients with medically refractory temporal lobe epilepsy. However, the ability of certain patterns of metabolic landscape to predict postsurgical seizure outcome has not been well characterized. The purpose of this retrospective study was to determine whether FDG PET abnormalities elsewhere in the brain, in combination with those in the temporal lobes, can be used to predict seizure outcome after surgery. Methods: Eighty patients with refractory temporal lobe seizures were imaged with PET after intravenous administration of 115 μCi/kg FDG. Images were interpreted without knowledge of clinical information by an experienced reviewer to determine seizure focus and regional metabolic changes in the brain. Metabolic activity scores were assigned for cortical and subcortical structures using the following criteria: 4 = normal activity, 3 = mildly decreased activity, 2 = moderately decreased activity, 1 = severely decreased activity, and 0 = no activity. A laterality index for each region was calculated using the equation 100 × [right − left]/[1/2 × (right + left)]. Seizure focus localization was based on the laterality of temporal lobe metabolic activity and was compared with that determined by scalp and depth electrodes and MRI results. Comparisons were made between asymmetries in metabolic activity in various brain structures and postoperative seizure frequency. Postoperative outcome was determined on the basis of cessation (complete disappearance of seizures) or continuation of seizure activity, regardless of frequency, compared with the preoperative state. Results: All 64 patients who were free of seizures postoperatively had either no thalamic asymmetry or reduced metabolism on the side from which the temporal lobe was removed. In contrast, 5 of 16 patients (31%) with postoperative seizures of any frequency had hypometabolism in the thalamus contralateral to that of the removed temporal lobe. All 5 patients with reverse thalamic asymmetry had postoperative seizures. Patients with thalamic hypometabolism ipsilateral to the removed temporal lobe also had an increased risk of postoperative seizures, but this risk was not as high as in patients with the contralateral abnormality. In these patients, the temporal lobe (which appeared hypometabolic on PET) was determined to be the site of the seizure on the basis of information besides that provided by PET before surgery. Conclusion: This study indicated that, in patients with temporal lobe epilepsy, thalamic metabolic asymmetry, particularly in the reverse direction to that of the temporal lobe asymmetry, was associated with a poor postsurgical outcome compared with no or matched asymmetry. This determination may be important in evaluating patients for, and selecting optimal candidates for, surgical intervention.

  • PET
  • seizure
  • thalamus
  • outcome

Complex partial seizures that are refractory to medical intervention can often be treated successfully with temporal lobectomy in selected individuals. Several diagnostic tests have been used to localize the epileptogenic zone, and attempts have been made to determine the ability of such studies to predict postoperative seizure outcome. Specifically, PET, MRI, Wada's test, and electroencephalography (EEG, both surface and intracranial) have all been examined to determine whether they are capable of assessing outcomes after surgery (1,2). On FDG PET studies, temporal lobe hypometabolism has been shown to predict postoperative seizure outcome (3–5). Thus, after temporal lobectomy, patients with greater temporal lobe hypometabolism on the side that EEG determined to be the focus of the seizure tend to have a better postoperative outcome than do patients without temporal lobe hypometabolism on that side.

The purpose of this study was to review FDG PET findings for a large sample of patients with temporal lobe epilepsy and determine the most useful metabolic predictors of postoperative seizure outcome. Attention was focused on both cortical and subcortical structures to determine if widespread or unusual observations might be associated with a poor outcome. Such an association is clearly present in patients who show multiple seizure foci as assessed on EEG and FDG PET scans (4,6). Our aim was to determine the value of such analyses in predicting seizure outcome in patients with temporal lobe epilepsy after surgery.

MATERIALS AND METHODS

Subject Selection

Eighty patients with medically refractory temporal lobe seizures (43 women, 37 men; age range, 17–56 y) were referred for FDG PET as part of a preoperative assessment protocol. Sixty-nine patients were right handed, and 11 were left handed. Medical failure was defined as a lack of therapeutic response or allergy to a least 3 anticonvulsant drugs in monotherapy and 1 combination (7). These patients also underwent Wada's test, surface and intracranial (when necessary) interictal and ictal EEG neuropsychologic tests, and MRI to detect and identify the possible seizure focus for surgical excision (7). All patients subsequently underwent temporal lobectomy.

Surgical Procedure

A standard excision was performed on all patients, although a modest trend was seen toward removing a larger amount of posterior mesial tissue over the duration of the study (7). In patients with dominant lobectomies, the resection was typically carried back laterally approximately 4.5–5.0 cm from the temporal tip. In patients with nondominant lobectomies, the resection measured 5.0–5.5 cm from the temporal tip. The amygdala and the anterior 1.5–3.0 cm of the hippocampus were removed.

Postoperative Seizure Outcome

Patients were evaluated for postoperative seizure frequency at regular intervals (2 wk, 2 mo, 6 mo, and 1 y) for 1 y after surgery and were categorized as either seizure free or not seizure free at 1 y.

PET

PET was performed according to previously described methods (8). Briefly, an intravenous catheter was inserted under local anesthesia. The eyes were open, the ears were nonoccluded, and ambient noise and light was kept to a minimum during the study. FDG, 115 μCi/kg, was then injected intravenously. PET was initiated 40 min after the administration of FDG. Images were obtained with the PENN PET (9) scanner (UGM, Philadelphia, PA) with a resolution of 5.5 mm in all 3 planes. The head was fixed in place throughout the study, and the correctness of the positioning was monitored by an investigator or technologist. EEG was not performed at the time of PET. Three-dimensional data were acquired with this system, and the images were reconstructed in all 3 planes, with a slice thickness of 6–8 mm. Attenuation was corrected using the method of Chang (10).

Image Analysis

The metabolic activity of various anatomic structures as visualized on images was evaluated by an experienced nuclear medicine physician who was unaware of clinical or other localizing information. All 3 planes were examined for this analysis, and particular attention was paid to the coronal-section abnormalities, which were considered critical for the aim of this study. Individual areas of the temporal, frontal, parietal, and occipital lobes and the thalami and basal ganglia were qualitatively scored for the degree of metabolic activity using the following rating system: 4 = normal activity, 3 = mildly decreased activity, 2 = moderately decreased activity, 1 = severely decreased activity, and 0 = no activity. The level of metabolic activity was defined relative to adjacent structures and the overall pattern by reviewing the entire image set. The FDG PET result was considered abnormal if any decrease in metabolism was seen, and asymmetry was considered present if a difference of 1 point or more in the qualitative score occurred. The reviewer had considerable experience in the evaluation of FDG PET scans of both healthy volunteers and patients with central nervous system disorders (11). A laterality index (LI) was calculated for each area, as well as for the medial, lateral, and inferior aspects of the temporal lobes, using the equation 100 × [right − left]/[1/2 × (right + left)]. The medial, lateral, and inferior aspects of the temporal lobes were evaluated with separate scores for the transaxial images and the coronal images.

Data Analysis

Seizure outcome data were compared with preoperative metabolic measures for each structure using the Fisher exact test. Exact 95% binomial confidence intervals around the estimates or risk were calculated.

RESULTS

Of the 80 patients studied (Table 1), 64 (80%) were seizure free and 16 (20%) had postoperative seizures at the 1-y follow-up evaluation. Of the 64 patients who were seizure free postoperatively, all had either no thalamic metabolic asymmetry or asymmetry in the same direction as that of the removed temporal lobe (i.e., the thalamus ipsilateral to the hypometabolic temporal lobe appeared to have reduced metabolism; Fig. 1). No patients who were seizure free had thalamic asymmetry in the reverse direction to that of the removed temporal lobe (i.e., the thalamus contralateral to the hypometabolic temporal lobe appeared to have reduced metabolism). In contrast, 5 of 16 patients (31%) with postoperative seizures of any degree had thalamic asymmetry in the reverse direction to that of the removed temporal lobe (Fig. 2). Furthermore, all 5 patients with this reverse thalamic asymmetry were found to have some degree of postoperative seizures. All patients in the study underwent similar surgery based on their clinical findings, and patients with postoperative seizures, in retrospective analysis, had no identifiable differences in the surgery performed. Further, patients with postoperative seizures did not have conflicting clinical results preoperatively that might have indicated the potential for a poorer postsurgical outcome.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Transaxial images of patient with temporal lobe epilepsy show markedly decreased metabolism in right temporal lobe (B) and in ipsilateral thalamus (A).

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Transaxial images of patient with temporal lobe epilepsy show markedly decreased metabolism in right temporal lobe (B), particularly in medial aspect, and in contralateral thalamus (A).

View this table:
  • View inline
  • View popup
TABLE 1.

Relationship Between Thalamic Asymmetry and Postoperative Seizures

The risk for postoperative seizures (Table 1) in patients with reverse thalamic asymmetry was calculated to be 1.0 (95% confidence interval, 0.48–1.0), whereas the risk in patients with thalamic asymmetry in the same direction as the temporal lobe asymmetry (ipsilateral asymmetry) was 0.22 (95% confidence interval, 0.10–0.38) and the risk in patients without thalamic asymmetry was 0.08 (95% confidence interval, 0.02–0.21). Thus, the patients with the lowest risk of postoperative seizures were those with no thalamic asymmetry. Patients with ipsilateral thalamic asymmetry had a higher risk, and patients with reverse thalamic asymmetry had the highest risk. For the general test of association between seizure occurrence and thalamic asymmetry, the Fisher's exact test revealed a probability value less than 0.001. A between-group comparison of patients with thalamic asymmetry in the same direction as the temporal lobe asymmetry and patients with no asymmetry yielded a probability value of 0.113 for the Fisher's exact test; between patients with reverse thalamic asymmetry and patients with thalamic asymmetry in the same direction as that of the temporal lobes, the Fisher's exact test revealed a probability value of 0.002; and between patients with reverse thalamic asymmetry and patients with no thalamic asymmetry, the Fisher's exact test revealed a probability value of 0.001. We discerned no MRI, EEG, surgical, or other clinical factors that could account for the postoperative seizure outcome. That is, patients with postoperative seizures had no identifiable cause that distinguished them from patients without postoperative seizures.

An analysis of temporal lobe findings showed an 88% sensitivity and 95% specificity for PET seizure focus localization based on a comparison between the observed temporal lobe hypometabolism and the final site of temporal lobectomy.

Using the LI, temporal lobe metabolism was compared with postoperative seizure outcome. Using the transaxial images, no clear pattern was seen for overall temporal lobe hypometabolism and the presence of postoperative seizures. However, the LI calculated using the coronal images showed several relationships between temporal lobe hypometabolism and postoperative seizure frequency (Table 2). In particular, greater temporal lobe asymmetry (as shown by an increased LI) for the entire temporal lobe, the lateral temporal lobe, and the inferior temporal lobe was associated with a relatively lower occurrence of postoperative seizures. However, the LI for the medial temporal lobe showed no clear association with postoperative seizures. Also, no other cortical or subcortical regional asymmetries correlated significantly with postsurgical seizure frequency.

View this table:
  • View inline
  • View popup
TABLE 2.

Percentage of Patients with Postoperative Seizures Based on LI Determined Using Coronal Images

DISCUSSION

A major new finding from this study was that patients with relative contralateral thalamic hypometabolism, compared with the surgically removed temporal lobe (i.e., reverse thalamic asymmetry), were not seizure free postoperatively. Further, 31% of patients with any degree of postoperative seizure activity had reverse thalamic asymmetry. The observation that contralateral thalamic hypometabolism may be associated with a poor postoperative seizure outcome may have a physiologic explanation. Reverse thalamic asymmetry may reflect diffuse disease such that a greater portion of the temporal lobe or other areas, possibly even in the contralateral hemisphere, are involved in generating the seizure disorder. Patients with diffuse or multiple seizure foci will likely have a greater likelihood of postoperative seizures than those with limited and definable epileptogenic sites.

Although all 5 patients with reverse thalamic asymmetry had some degree of seizures postoperatively, reverse thalamic asymmetry was not a common finding. A larger sample size may show that some patients with reverse thalamic asymmetry have successful surgical outcomes. Furthermore, a closer analysis of postoperative seizure patterns showed that in patients with reverse thalamic asymmetry, seizures improved somewhat although residual seizure activity remained. Therefore, although patients with reverse thalamic asymmetry may have a poorer postoperative seizure outcome than patients without this metabolic pattern, until further prospective studies are performed, patients should not be excluded on this basis from surgery for temporal lobe seizures.

Thalamic hypometabolism ipsilateral to the temporal lobe seizure focus has previously been reported for temporal lobe epilepsy (12–14). Similarly, an interictal SPECT study revealed ipsilateral thalamic hypoperfusion (15). However, these studies did not correlate this finding with postsurgical outcome and did not report any cases of contralateral thalamic hypometabolism or hypoperfusion. We did find thalamic hypometabolism ipsilateral to the temporal lobe seizure focus, and these patients were at higher risk of postoperative seizures than were patients with no thalamic asymmetry. However, reverse thalamic asymmetry carried the highest risk of postoperative seizures.

Several studies have shown that a greater degree of hypometabolism found by FDG PET in the affected temporal lobe is associated with a higher likelihood of a seizure-free postoperative course (3,4,5,16). Furthermore, postoperative seizure outcome is improved in patients with hypometabolism restricted to the temporal lobes (4). Patients with extratemporal hypometabolism tend to have a higher likelihood of postoperative seizure activity (4,6,17). Other studies have shown that patients with a greater degree of hypometabolism in the temporal lobe (i.e., a more distinct asymmetry) tend to have a better outcome than those with a milder degree of asymmetry between the 2 sides (5,18,19). Patients without significant hypometabolism of 1 temporal lobe (i.e., minimal asymmetry between the temporal lobes) may conceivably suffer from extratemporal or bitemporal seizure origins. These patients may not, therefore, be optimal candidates for surgical resection. Several studies have indicated that patients with mesial temporal hypometabolism on PET had a higher probability of becoming seizure free postoperatively than did patients with hypometabolism in other parts of the temporal lobe (18). However, other studies have suggested that lateral temporal lobe hypometabolism is a better predictor of a seizure-free postoperative course (19). Our study suggests that the greater the temporal lobe hypometabolism, particularly in the lateral and inferior aspect (as determined by an increased LI), the lower is the chance of postoperative seizures. Thus, the more asymmetric the temporal lobes, the better was the subject's chance of being seizure free postoperatively. This finding is consistent with the findings of previous studies (3,4,5,18,19). However, 2 other studies have not shown such a clear relationship between temporal lobe hypometabolism and postoperative outcomes (20,21).

CONCLUSION

This study investigated metabolic patterns that might predict poor postoperative seizure outcome in patients with temporal lobe epilepsy. The overall success rate of temporal lobectomy for medically refractory seizures was similar to that previously reported (22). Lower metabolism in the removed temporal lobe was associated with a lower risk of postoperative seizures. Thalamic asymmetry was the only other finding associated with postoperative seizure outcome. Reverse thalamic metabolic asymmetry was associated with a significantly higher likelihood of postoperative seizures than was no asymmetry or asymmetry in the same direction as that of the temporal lobes. However, thalamic asymmetry in the same direction as that of the temporal lobes also was associated with a higher likelihood of postoperative seizures after temporal lobectomy than was no asymmetry.

Footnotes

  • Received Dec. 13, 1999; revision accepted Jun. 30, 2000.

    For correspondence or reprints contact: Andrew B. Newberg, MD, Division of Nuclear Medicine, 110 Donner Bldg., H.U.P., 3400 Spruce St., Philadelphia, PA 19104.

REFERENCES

  1. ↵
    Engel J Jr. Current concepts: surgery for seizures. N Engl J Med. 1996;334:647–652.
    OpenUrlCrossRefPubMed
  2. ↵
    Benbadis SR, So NK, Antar MA, et al. The value of PET scan (and MRI and Wada test) in patients with bitemporal epileptiform abnormalities. Arch Neurol. 1995;52:1062–1068.
    OpenUrlCrossRefPubMed
  3. ↵
    Wong C-Y, Geller EB, Chen EQ, et al. Outcome of temporal lobe epilepsy surgery predicted by statistical parametric PET imaging. J Nucl Med. 1996;37:1094–1100.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Manno EM, Sperling MR, Ding X, et al. Predictors of outcome after anterior temporal lobectomy: positron emission tomography. Neurology. 1994;44:2331–2336.
    OpenUrlPubMed
  5. ↵
    Radtke RA, Hanson MW, Hoffman JM, et al. Temporal lobe hypometabolism on PET: predictor of seizure control after temporal lobectomy. Neurology. 1993;43:1088–1092.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Swartz BE, Tomiyasu U, Delgado-Escueta AV, Mandelkern M, Khonsari A. Neuroimaging in temporal lobe epilepsy: test sensitivity and relationships to pathology and postoperative outcome. Epilepsia. 1992;33:624–634.
    OpenUrlCrossRefPubMed
  7. ↵
    Sperling MR, O'Connor MJ, Saykin AJ, Plummer C. Temporal lobectomy for refractory epilepsy. JAMA. 1996;276:470–475.
    OpenUrlCrossRefPubMed
  8. ↵
    Alavi A, Dann R, Chawluk J, et al. Positron emission tomography imaging of regional cerebral glucose metabolism. Semin Nucl Med. 1986;16:2–34.
    OpenUrlCrossRefPubMed
  9. ↵
    Karp JS, Muehllehner G, Mankoff DA, et al. Continuous-slice PENN-PET: a positron tomograph with volume imaging capability. J Nucl Med. 1990;31:617–627.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci. 1978;25:638–643.
    OpenUrlCrossRef
  11. ↵
    Loessner A, Alavi A, Lewandrowski KU, et al. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. J Nucl Med 1995;36:1141–1149.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Rubin E, Dhawan V, Moeller JR, et al. Cerebral metabolic topography in unilateral temporal lobe epilepsy. Neurology. 1995;45:2212–2223.
    OpenUrlAbstract/FREE Full Text
  13. Khan N, Leenders KL, Hajek M, et al. Thalamic glucose metabolism in temporal lobe epilepsy measured with 18F-FDG positron emission tomography (PET). Epilepsy Res. 1997;28:233–243.
    OpenUrlCrossRefPubMed
  14. ↵
    Henry TR, Sutherling WW, Engel J Jr, et al. Interictal cerebral metabolism in partial epilepsies of neocortical origin. Epilepsy Res. 1991;10:174–182.
    OpenUrlCrossRefPubMed
  15. ↵
    Yune MJ, Lee JD, Ryu YH, et al. Ipsilateral thalamic hypoperfusion on interictal SPECT in temporal lobe epilepsy. J Nucl Med. 1998;39:281–285.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Theodore WH, Sato S, Kufta CV, et al. FDG-positron emission tomography and invasive EEG: seizure focus detection and surgical outcome. Epilepsia. 1997;38:81–86.
    OpenUrlCrossRefPubMed
  17. ↵
    Blum DE, Ehsan T, Dungan D, et al. Bilateral temporal hypometabolism in epilepsy. Epilepsia. 1998;39:651–659.
    OpenUrlCrossRefPubMed
  18. ↵
    Delbeke D, Lawrence SK, Abou-Khalil BW, et al. Postsurgical outcome of patients with uncontrolled complex partial seizures and temporal lobe hypometabolism on 18FDG-positron emission tomography. Invest Radiol. 1996;31:261–266.
    OpenUrlCrossRefPubMed
  19. ↵
    Theodore WH, Sato S, Kufta C, et al. Temporal lobectomy for uncontrolled seizures: the role of positron emission tomography. Ann Neurol. 1992;32:789–794.
    OpenUrlCrossRefPubMed
  20. ↵
    Engel J, Babb TL, Phelps ME. Contributions of positron emission tomography to understanding mechanisms of epilepsy. In: Engel J Jr, Ojemann GA, Luders HO, Williamson PD, eds. Fundamental Mechanisms of Human Brain Function New York, NY: Raven Press; 1987:209–218.
  21. ↵
    Theodore WH, Katz D, Kufta C, et al. Pathology of temporal lobe foci: correlation with CT, MRI and PET. Neurology. 1990;40:797–803.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Salanova V, Markand O, Worth R. Longitudinal follow-up in 145 patients with medically refractory temporal lobe epilepsy treated surgically between 1984 and 1995. Epilepsia. 1999;40:1417–1423.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 41, Issue 12
December 1, 2000
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ipsilateral and Contralateral Thalamic Hypometabolism as a Predictor of Outcome After Temporal Lobectomy for Seizures
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Ipsilateral and Contralateral Thalamic Hypometabolism as a Predictor of Outcome After Temporal Lobectomy for Seizures
Andrew B. Newberg, Abass Alavi, Jesse Berlin, P. David Mozley, Michael O'Connor, Michael Sperling
Journal of Nuclear Medicine Dec 2000, 41 (12) 1964-1968;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Ipsilateral and Contralateral Thalamic Hypometabolism as a Predictor of Outcome After Temporal Lobectomy for Seizures
Andrew B. Newberg, Abass Alavi, Jesse Berlin, P. David Mozley, Michael O'Connor, Michael Sperling
Journal of Nuclear Medicine Dec 2000, 41 (12) 1964-1968;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • 18F-FDG-PET patterns of surgical success and failure in mesial temporal lobe epilepsy
  • The Role of Radionuclide Imaging in Epilepsy, Part 1: Sporadic Temporal and Extratemporal Lobe Epilepsy
  • The Role of Radionuclide Imaging in Epilepsy, Part 1: Sporadic Temporal and Extratemporal Lobe Epilepsy
  • The Cost-Effective Use of 18F-FDG PET in the Presurgical Evaluation of Medically Refractory Focal Epilepsy
  • A subcortical network of dysfunction in TLE measured by magnetic resonance spectroscopy
  • Does Asymmetric Basal Ganglia or Thalamic Activation Aid in Seizure Foci Lateralization on Ictal SPECT Studies?
  • Google Scholar

More in this TOC Section

  • Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
  • Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer 18F-FDG PET Radiomics
  • The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma
Show more CLINICAL INVESTIGATIONS

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire